Financings Of The Fortnight: Why Are Royalty-Based Financings On The Rise Again?
This article was originally published in The Pink Sheet Daily
Executive Summary
Plus news on recent financings by Vivus, Novira Therapeutics, Theraclone Sciences and Receptos.